Insider Transactions in Q4 2020 at Abeona Therapeutics Inc. (ABEO)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Paul Elliot Mann Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
609,755
-78.89%
|
-
|
|
Dec 31
2020
|
Todd Wider Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
609,755
-66.26%
|
-
|
|
Dec 18
2020
|
Paul Elliot Mann Director |
SELL
Open market or private sale
|
Direct |
17,079
-2.16%
|
$17,079
$1.59 P/Share
|
|
Dec 02
2020
|
Paul Elliot Mann Director |
SELL
Open market or private sale
|
Direct |
30,488
-3.72%
|
$30,488
$1.49 P/Share
|
|
Dec 02
2020
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
33,876
-3.55%
|
$33,876
$1.49 P/Share
|
|
Nov 23
2020
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
17,969
-1.85%
|
$17,969
$1.33 P/Share
|
|
Nov 02
2020
|
Paul Elliot Mann Director |
SELL
Open market or private sale
|
Direct |
30,488
-3.58%
|
$30,488
$1.04 P/Share
|
|
Nov 02
2020
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
33,876
-3.37%
|
$33,876
$1.04 P/Share
|
|
Oct 09
2020
|
Edward Carr Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
143,182
+42.12%
|
-
|
|
Oct 08
2020
|
Todd Wider Director |
BUY
Grant, award, or other acquisition
|
Direct |
813,008
+44.7%
|
-
|
|
Oct 08
2020
|
Paul Elliot Mann Director |
BUY
Grant, award, or other acquisition
|
Direct |
813,008
+48.86%
|
-
|